US3914250A
(en)
|
1974-08-01 |
1975-10-21 |
American Home Prod |
1,4-Diazepino{8 6,5,4-jk{9 carbazoles
|
CA1258454A
(fr)
|
1982-08-10 |
1989-08-15 |
Leo Alig |
Phenethanolamines
|
IT1159765B
(it)
|
1982-09-28 |
1987-03-04 |
Zanussi A Spa Industrie |
Macchina lavabiancheria di tipo modulare
|
ZA848275B
(en)
|
1983-12-28 |
1985-08-28 |
Degussa |
New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
|
MX18467A
(es)
|
1988-11-23 |
1993-07-01 |
Pfizer |
Agentes terapeuticos de quinuclidinas
|
US5232929A
(en)
|
1990-11-28 |
1993-08-03 |
Pfizer Inc. |
3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
|
US5081122A
(en)
|
1990-03-05 |
1992-01-14 |
Sterling Drug Inc. |
Antiglaucoma compositions containing 4-arylcarbonyl-1-(4-morpholinyl)-lower-alkyl)-1H-indoles and method of use thereof
|
US5112820A
(en)
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
US5013837A
(en)
|
1990-03-08 |
1991-05-07 |
Sterling Drug Inc. |
3-Arylcarbonyl-1H-indole-containing compounds
|
US4973587A
(en)
|
1990-03-08 |
1990-11-27 |
Sterling Drug Inc. |
3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
|
US5242930A
(en)
|
1991-02-11 |
1993-09-07 |
Merck Sharp & Dohme Ltd. |
Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
|
DK0573522T3
(da)
|
1991-03-01 |
1995-03-06 |
Pfizer |
1-Azabicyclo(3,2,2)nonan-3-aminderivater
|
EP0528495A1
(fr)
|
1991-08-20 |
1993-02-24 |
Merck Sharp & Dohme Ltd. |
Composés azacycliques, leur préparation et compositions pharmaceutiques les contenant
|
GB9211193D0
(en)
|
1992-05-27 |
1992-07-08 |
Merck Sharp & Dohme |
Therapeutic agents
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
US5637699A
(en)
|
1992-06-29 |
1997-06-10 |
Merck & Co., Inc. |
Process for preparing morpholine tachykinin receptor antagonists
|
US5387595A
(en)
|
1992-08-26 |
1995-02-07 |
Merck & Co., Inc. |
Alicyclic compounds as tachykinin receptor antagonists
|
US5578593A
(en)
|
1992-12-11 |
1996-11-26 |
Merck & Co., Inc. |
Spiro piperidines and homologs promote release of growth hormone
|
US5292736A
(en)
|
1993-02-26 |
1994-03-08 |
Sterling Winthrop Inc. |
Morpholinoalkylindenes as antiglaucoma agents
|
US5496833A
(en)
|
1993-04-13 |
1996-03-05 |
Merck Sharp & Dohme Limited |
Piperidine tachykinin receptor antagonists
|
PL321136A1
(en)
|
1994-11-07 |
1997-11-24 |
Pfizer |
Some substituted derivatives of bencylamine as a new class of specific ligands of neuropeptide y1
|
US5532237A
(en)
|
1995-02-15 |
1996-07-02 |
Merck Frosst Canada, Inc. |
Indole derivatives with affinity for the cannabinoid receptor
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
US5739106A
(en)
|
1995-06-07 |
1998-04-14 |
Rink; Timothy J. |
Appetite regulating compositions
|
FR2741621B1
(fr)
|
1995-11-23 |
1998-02-13 |
Sanofi Sa |
Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant
|
WO1997020823A2
(fr)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Antagonistes de recepteurs
|
WO1997020822A1
(fr)
|
1995-12-01 |
1997-06-12 |
Novartis Ag |
Quinazolin-2,4-diazirines en tant qu'antagoniste du recepteur du neuropeptide y
|
AU7692696A
(en)
|
1995-12-01 |
1997-06-27 |
Novartis Ag |
Heteroaryl derivatives
|
AU1328197A
(en)
|
1995-12-01 |
1997-06-19 |
Synaptic Pharmaceutical Corporation |
Aryl sulfonamide and sulfamide derivatives and uses thereof
|
AU7626496A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Heteroaryl compounds
|
TW432073B
(en)
|
1995-12-28 |
2001-05-01 |
Pfizer |
Pyrazolopyridine compounds
|
WO1997028149A1
(fr)
|
1996-02-02 |
1997-08-07 |
Merck & Co., Inc. |
Procede pour augmenter les niveaux de cholesterol hdl
|
WO1997029079A1
(fr)
|
1996-02-06 |
1997-08-14 |
Japan Tobacco Inc. |
Composes chimiques et utilisation pharmaceutique
|
GB9606805D0
(en)
|
1996-03-30 |
1996-06-05 |
Glaxo Wellcome Inc |
Medicaments
|
US6043246A
(en)
|
1996-12-03 |
2000-03-28 |
Banyu Pharmaceutical Co., Ltd. |
Urea derivatives
|
DE69719544T2
(de)
|
1996-12-12 |
2003-11-06 |
Banyu Pharma Co Ltd |
Pyrazolderivate
|
CA2274593A1
(fr)
|
1996-12-13 |
1998-06-18 |
Banyu Pharmaceutical Co., Ltd. |
Derives d'aminopyrazole
|
WO1998027063A1
(fr)
|
1996-12-16 |
1998-06-25 |
Banyu Pharmaceutical Co., Ltd. |
Derives d'aminopyrazole
|
US6100259A
(en)
|
1997-01-21 |
2000-08-08 |
Smithkline Beecham Corporation |
Cannabinoid receptor modulators
|
CN1246845A
(zh)
|
1997-02-04 |
2000-03-08 |
纳幕尔杜邦公司 |
杀菌的羧酰胺
|
RU2203272C2
(ru)
|
1997-02-21 |
2003-04-27 |
Байер Акциенгезелльшафт |
Замещенные бициклические соединения, исходные и промежуточные продукты для их получения и фармацевтическая композиция на их основе
|
AU6309698A
(en)
|
1997-03-12 |
1998-09-29 |
Banyu Pharmaceutical Co., Ltd. |
Drugs containing aminopyridine derivatives as the active ingredient
|
EP0979228A4
(fr)
|
1997-03-18 |
2000-05-03 |
Smithkline Beecham Corp |
Nouveaux agonistes de recepteurs de cannabinoides
|
FR2761266B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates
|
FR2761265B1
(fr)
|
1997-03-28 |
1999-07-02 |
Sanofi Sa |
Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
|
EP0992239B1
(fr)
|
1997-04-23 |
2003-03-12 |
Banyu Pharmaceutical Co., Ltd. |
Antagoniste de recepteur de neuropeptide y
|
US6001836A
(en)
|
1997-05-28 |
1999-12-14 |
Bristol-Myers Squibb Company |
Dihydropyridine NPY antagonists: cyanoguanidine derivatives
|
KR20010021696A
(ko)
|
1997-07-11 |
2001-03-15 |
미즈노 마사루 |
퀴놀린 화합물 및 그의 의약용도
|
AR016817A1
(es)
|
1997-08-14 |
2001-08-01 |
Smithkline Beecham Plc |
Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento
|
AU9185598A
(en)
|
1997-09-25 |
1999-04-12 |
Banyu Pharmaceutical Co., Ltd. |
Novel neuropeptide y receptor antagonists
|
WO1999027965A1
(fr)
|
1997-11-28 |
1999-06-10 |
Banyu Pharmaceutical Co., Ltd. |
Agents anti-hyperlipemiques
|
WO1999051600A1
(fr)
|
1998-04-02 |
1999-10-14 |
Neurogen Corporation |
DERIVES AMINOALKYLE SUBSTITUES DE 9H-PYRIDINO [2,3-b]INDOLE ET 9H-PYRIMIDINO [4,5-b]INDOLE
|
ES2223170T3
(es)
|
1998-04-29 |
2005-02-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aminotetralinas n sustituidas, ligandos del receptor y y5 del neuropeptido que sirve para el tratamiento de la obesidad y otros trastornos.
|
EP1075478B1
(fr)
|
1998-05-08 |
2003-04-16 |
SmithKline Beecham plc |
Derives de phenyluree et de (phenylthio)uree
|
US6329395B1
(en)
|
1998-06-08 |
2001-12-11 |
Schering Corporation |
Neuropeptide Y5 receptor antagonists
|
HN1998000027A
(es)
|
1998-08-19 |
1999-06-02 |
Bayer Ip Gmbh |
Arilsulfonamidas y analagos
|
DE19837627A1
(de)
|
1998-08-19 |
2000-02-24 |
Bayer Ag |
Neue Aminosäureester von Arylsulfonamiden und Analoga
|
US6358951B1
(en)
|
1998-08-21 |
2002-03-19 |
Pfizer Inc. |
Growth hormone secretagogues
|
US6337332B1
(en)
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
AU756797B2
(en)
|
1998-11-10 |
2003-01-23 |
Banyu Pharmaceutical Co., Ltd. |
Spiro-indolines as Y5 receptor antagonists
|
AU2910600A
(en)
|
1999-02-12 |
2000-08-29 |
Smithkline Beecham Plc |
Phenyl urea and phenyl thiourea derivatives
|
WO2000047576A1
(fr)
|
1999-02-12 |
2000-08-17 |
Smithkline Beecham Plc |
Derives de cinnamide utilises en tant qu'antagonistes des recepteurs de l'orexine-1
|
EP1150977B1
(fr)
|
1999-02-12 |
2004-08-25 |
SmithKline Beecham plc |
Derives de phenyluree et de phenylthiouree utilises comme antagonistes des recepteurs de l'orexine
|
PT1183245E
(pt)
|
1999-04-22 |
2007-07-12 |
Lundbeck & Co As H |
Antagonistas selectivos de npy (y5)
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
CA2373035A1
(fr)
|
1999-05-05 |
2000-11-16 |
Scott Dax |
Ligands de recepteurs du neuropeptide y derives de 3a,4,5,9b-tetrahydro-1h-benz[e]indol-2-yl amine, utilises pour le traitement de l'obesite et d'autres etats pathologiques
|
DE60023128T2
(de)
|
1999-05-12 |
2006-07-06 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyrazolcarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
|
EP1194421B1
(fr)
|
1999-06-30 |
2005-10-12 |
H. Lundbeck A/S |
Antagonistes selectifs du npy (y5)
|
WO2001007409A1
(fr)
|
1999-07-23 |
2001-02-01 |
Astrazeneca Uk Limited |
Derives de carbazole et leur utilisation en tant que ligands du recepteur de neuropeptide y5
|
HUP0202143A3
(en)
|
1999-07-28 |
2003-12-29 |
Ortho Mcneil Pharm Inc |
Amine and amide derivatives as ligands for the neuropeptide y y5 receptor pharmaceutical compositions containing them and their use
|
TWI279402B
(en)
|
1999-08-20 |
2007-04-21 |
Banyu Pharma Co Ltd |
Spiro compounds having NPY antagonistic activities and agents containing the same
|
US6462053B1
(en)
|
1999-08-20 |
2002-10-08 |
Banyu Pharmaceutical Co., Ltd. |
Spiro compounds
|
EP1219294A4
(fr)
|
1999-09-20 |
2005-01-26 |
|
Antagonistes de l'hormone de concentration de la melanine
|
CA2386474A1
(fr)
|
1999-09-20 |
2001-03-29 |
Takeda Chemical Industries, Ltd. |
Antagoniste de l'hormone de concentration de la melanine
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
YU23602A
(sh)
|
1999-09-30 |
2004-09-03 |
Neurogen Corporation |
Amino supstituisani pirazolo /1,5/a/-1,5-pirimidini i pirazolo /1,5-a/-1,3,5-triazini
|
WO2001023389A2
(fr)
|
1999-09-30 |
2001-04-05 |
Neurogen Corporation |
Hétérocycles à substitution alkylène-diamine
|
CZ20021067A3
(cs)
|
1999-09-30 |
2002-11-13 |
Neurogen Corporation |
Určité alkylendiaminové substituované pyrazolo[1,5-a]- 1,5-pyrimidiny a pyrazolo[1,5-a]-1,3,5-triaziny
|
BR0017025A
(pt)
|
1999-12-16 |
2003-01-07 |
Schering Corp |
Antagonistas do receptor y5 do neuropeptìdeo y de imidazola substituìda
|
AU779442B2
(en)
|
2000-01-20 |
2005-01-27 |
Eisai Co. Ltd. |
Novel piperidine compounds and drugs containing the same
|
WO2001056592A1
(fr)
|
2000-02-01 |
2001-08-09 |
Novo Nordisk A/S |
Utilisation de composes pour la regulation de l'absorption de nourriture
|
WO2001058869A2
(fr)
|
2000-02-11 |
2001-08-16 |
Bristol-Myers Squibb Company |
Modulateurs de recepteurs aux cannabinoides, leurs procedes de preparation et utilisations de modulateurs de recepteurs aux cannabinoides pour le traitement de maladies respiratoires et non respiratoires
|
ES2236178T3
(es)
|
2000-02-22 |
2005-07-16 |
Banyu Pharmaceutical Co., Ltd. |
Nuevos compuestos de imidazolina.
|
US6531478B2
(en)
|
2000-02-24 |
2003-03-11 |
Cheryl P. Kordik |
Amino pyrazole derivatives useful for the treatment of obesity and other disorders
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
EP1132389A1
(fr)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
Nouveaux dérivés de l'azaindole pour le traitement de l'obésité
|
JP4009460B2
(ja)
|
2000-03-14 |
2007-11-14 |
アクテリオン ファマシューティカルズ リミテッド |
1,2,3,4−テトラヒドロイソキノリン誘導体
|
EP1142886A1
(fr)
|
2000-04-07 |
2001-10-10 |
Aventis Pharma Deutschland GmbH |
Percyquinine, procédé pour sa production et son utilisation comme produit pharmaceutique
|
CA2407149C
(fr)
|
2000-04-28 |
2010-10-12 |
Takeda Chemical Industries, Ltd. |
Antagonistes de l'hormone concentrant la melanine
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
GB0011013D0
(en)
|
2000-05-09 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
WO2001085173A1
(fr)
|
2000-05-10 |
2001-11-15 |
Bristol-Myers Squibb Company |
Derives d'alkylamine d'antagonistes de dihydropyridine npy
|
US6444675B2
(en)
|
2000-05-10 |
2002-09-03 |
Bristol-Myers Squibb Company |
4-alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
|
US6432960B2
(en)
|
2000-05-10 |
2002-08-13 |
Bristol-Myers Squibb Company |
Squarate derivatives of dihydropyridine NPY antagonists
|
WO2001085693A1
(fr)
|
2000-05-11 |
2001-11-15 |
Banyu Pharmaceutical Co., Ltd. |
Dérivés n-acyltétrahydroisoquinoline
|
AU5959201A
(en)
|
2000-05-11 |
2001-11-20 |
Bristol Myers Squibb Co |
Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
|
AU2001256733A1
(en)
|
2000-05-16 |
2001-11-26 |
Takeda Chemical Industries Ltd. |
Melanin-concentrating hormone antagonist
|
AU2001259056A1
(en)
|
2000-05-17 |
2001-11-26 |
Eli Lilly And Company |
Method for selectively inhibiting ghrelin action
|
US6391881B2
(en)
|
2000-05-19 |
2002-05-21 |
Bristol-Myers Squibb Company |
Thiourea derivatives of dihydropyridine NPY antagonists
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
AU2001272476A1
(en)
|
2000-06-16 |
2001-12-24 |
Smithkline Beecham Plc |
Piperidines for use as orexin receptor antagonists
|
JP2004504303A
(ja)
|
2000-07-05 |
2004-02-12 |
シナプティック・ファーマスーティカル・コーポレーション |
選択的メラニン凝集ホルモン−1(mch1)受容体アンタゴニストおよびその使用
|
AU2001279294A1
(en)
|
2000-07-06 |
2002-01-21 |
Neurogen Corporation |
Melanin concentrating hormone receptor ligands
|
AU2001283938A1
(en)
|
2000-07-24 |
2002-02-05 |
Ardana Bioscience Limited |
Ghrelin antagonists
|
BR0112918A
(pt)
|
2000-07-31 |
2003-07-01 |
Hoffmann La Roche |
Composto, utilização do mesmo, processo de tratamento de distúrbios, processo para a preparação de composto, composição farmacêutica que compreende esse composto, processo para preparar uma composição e processo de tratamento de obesidade em um ser humano
|
AU2001294547A1
(en)
|
2000-09-14 |
2002-03-26 |
Schering Corporation |
Substituted urea neuropeptide y y5 receptor antagonists
|
PT1326851E
(pt)
|
2000-10-13 |
2004-11-30 |
Lilly Co Eli |
Dipeptidos substituidos como secretagogues da hormona do crescimento
|
AU2167002A
(en)
|
2000-10-16 |
2002-06-11 |
Hoffmann La Roche |
Indoline derivatives and their use as 5-ht2 receptor ligands
|
WO2002036596A2
(fr)
|
2000-11-03 |
2002-05-10 |
Wyeth |
Cycloalkyl[b][1,4]diazepino[6,7,1-hi]indoles et derives
|
AU2426602A
(en)
|
2000-11-20 |
2002-05-27 |
Biovitrum Ab |
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
|
NZ525699A
(en)
|
2000-11-20 |
2005-03-24 |
Biovitrum Ab |
Piperazinylpyrazines compounds as antagonists of serotonin 5-HT2 receptor
|
AU2002224885A1
(en)
|
2000-11-28 |
2002-06-11 |
Smithkline Beecham Plc |
Morpholine derivatives as antagonists of orexin receptors
|
ES2249384T3
(es)
|
2000-12-12 |
2006-04-01 |
Neurogen Corporation |
Espiro(isobenzofuran-1,4'-piperadin)-3-onas y 3h-espirobenzofuran-1,4-piperidinas.
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
ES2316486T3
(es)
|
2000-12-21 |
2009-04-16 |
Schering Corporation |
Antagonsitas de los receptores y5 del neuropeptido y heteroaril-urea.
|
CN1273451C
(zh)
|
2000-12-22 |
2006-09-06 |
先灵公司 |
哌啶mch拮抗剂及其治疗肥胖症的用途
|
BR0116605A
(pt)
|
2000-12-27 |
2003-09-30 |
Hoffmann La Roche |
Composto, processo para a preparação de um composto, composição farmacêutica que compreende o mesmo, sua utilização e processo para o tratamento e profilaxia de distúrbios do sistema nervoso central, distúrbios cardiovasculares, distúrbios gastrintestinais e apnéia do sono
|
WO2002051232A2
(fr)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Nouvelles benzazepines et derives heterocycliques associes
|
IL157179A0
(en)
|
2001-02-02 |
2004-02-08 |
Takeda Chemical Industries Ltd |
Fused heterocyclic compounds
|
CN100537527C
(zh)
|
2001-03-21 |
2009-09-09 |
法马科皮亚公司 |
具有mch调节活性的芳基和二芳基化合物
|
US6900329B2
(en)
|
2001-03-21 |
2005-05-31 |
Schering Corporation |
MCH antagonists and their use in the treatment of obesity
|
SI1373216T1
(en)
|
2001-03-22 |
2005-06-30 |
Solvay Pharmaceuticals B.V. |
4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
|
AR035234A1
(es)
|
2001-04-12 |
2004-05-05 |
Pharmacopeia Drug Discovery |
Aril y biaril-piperidinas con actividad moduladora mch, metodo para preparar dichos compuestos, composiciones farmaceuticas, metodo para preparar las composiciones farmaceuticas y el uso de dichos compuestos para la manufactura de un medicamento
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
EP1435955A2
(fr)
|
2001-05-05 |
2004-07-14 |
SmithKline Beecham P.L.C. |
Derives d'amines cycliques n-aroyl utilises comme antagonistes du recepteur d'orexine
|
US7432270B2
(en)
|
2001-05-05 |
2008-10-07 |
Smithkline Beecham P.L.C. |
N-aroyl cyclic amines
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
WO2002094825A1
(fr)
|
2001-05-22 |
2002-11-28 |
Banyu Pharmaceutical Co., Ltd. |
Nouveau derive de spiropiperidine
|
IL158941A0
(en)
|
2001-05-22 |
2004-05-12 |
Neurogen Corp |
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
|
ATE381539T1
(de)
|
2001-06-20 |
2008-01-15 |
Merck & Co Inc |
Dipeptidylpeptidase-hemmer zur behandlung von diabetes
|
JP2005500308A
(ja)
|
2001-06-20 |
2005-01-06 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病を治療するためのジペプチジルペプチダーゼ阻害剤
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
ATE370943T1
(de)
|
2001-06-27 |
2007-09-15 |
Smithkline Beecham Corp |
Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren
|
US7196201B2
(en)
|
2001-06-27 |
2007-03-27 |
Smithkline Beecham Corporation |
Pyrrolidines as dipeptidyl peptidase inhibitors
|
CA2419888A1
(fr)
|
2001-06-27 |
2003-01-09 |
Probiodrug Ag |
Structures peptidiques utiles pour la modulation competitive de la catalyse de dipeptidyle peptidase iv
|
DE60222667T2
(de)
|
2001-06-27 |
2008-07-17 |
Smithkline Beecham Corp. |
Fluorpyrrolidine als dipeptidylpeptidaseinhibitoren
|
JP4399256B2
(ja)
|
2001-06-28 |
2010-01-13 |
スミスクライン ビーチャム ピー エル シー |
オレキシン受容体アンタゴニストとしてのn−アロイル環状アミン誘導体
|
GB0115862D0
(en)
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
EP1404675B1
(fr)
|
2001-07-03 |
2008-03-12 |
Novo Nordisk A/S |
Derives de purine inhibiteurs de dpp-iv pour le traitement du diabete
|
KR20040027870A
(ko)
|
2001-07-05 |
2004-04-01 |
시냅틱 파마세틱칼 코포레이션 |
Mch 선택적인 안타고니스트로서의 치환 아닐린 피페리딘
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
WO2003007887A2
(fr)
|
2001-07-20 |
2003-01-30 |
Merck & Co., Inc. |
Imidazoles substitues servant de modulateurs de recepteurs de cannabinoides
|
BRPI0104510B8
(pt)
|
2001-07-27 |
2021-05-25 |
Embrapa Pesquisa Agropecuaria |
peptídeos antibióticos da família das phylloseptinas isolados da secreção da pele de phylloseptina hypocondrialis e composição antimicrobiana relacionada
|
HUP0401108A2
(hu)
|
2001-08-07 |
2004-09-28 |
Banyu Pharmaceutical Co., Ltd. |
Spirovegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
GB0126292D0
(en)
|
2001-11-01 |
2002-01-02 |
Smithkline Beecham Plc |
Compounds
|
GB0127145D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Compounds
|
GB0130393D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
GB0130335D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
GB0130341D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
JP2005320249A
(ja)
|
2002-05-01 |
2005-11-17 |
Banyu Pharmaceut Co Ltd |
2−アミノピラジン誘導体の製造方法
|
TWI283241B
(en)
|
2002-05-29 |
2007-07-01 |
Tanabe Seiyaku Co |
Novel piperidine compound
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
CA2460051A1
(fr)
|
2002-07-09 |
2004-01-15 |
Actelion Pharmaceuticals Ltd. |
Derives de 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido et 2,3-dihydro-2h-pyrrolo[2,1-b]-quinazolinone
|
EP1539747B1
(fr)
|
2002-09-18 |
2006-11-02 |
Glaxo Group Limited |
Amines cycliques n-aroyle utilisees comme antagonistes du recepteur d'orexine
|
US6869966B2
(en)
|
2002-09-30 |
2005-03-22 |
Banyu Pharmaceutical Co., Ltd. |
N-substituted-2-oxodihydropyridine derivatives
|
US20060166966A1
(en)
|
2002-10-08 |
2006-07-27 |
Cameron Black |
4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis
|
CA2498091C
(fr)
|
2002-10-11 |
2011-03-22 |
Actelion Pharmaceuticals Ltd. |
Derives d'acide sulfonylaminoacetique
|
GB0225884D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225938D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
MY134457A
(en)
|
2002-11-22 |
2007-12-31 |
Merck & Co Inc |
Substituted amides
|
AU2003299648A1
(en)
|
2002-12-12 |
2004-06-30 |
Janssen Pharmaceutica, N.V. |
Substituted 4-phenyl-(1,3)-dioxanes
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
CL2004000553A1
(es)
|
2003-03-20 |
2005-02-04 |
Actelion Pharmaceuticals Ltd |
Uso de compuestos derivados de guanidina como antagonistas del receptor de neuropeptido ff; compuestos derivados de guanidina; procedimientos de preparacion; y composicion farmaceutica que los comprende.
|
CN100432056C
(zh)
|
2003-03-26 |
2008-11-12 |
埃科特莱茵药品有限公司 |
四氢异喹啉基乙酰胺衍生物作为阿立新受体拮抗剂的应用
|
JO2355B1
(en)
|
2003-04-15 |
2006-12-12 |
ميرك شارب اند دوم كوربوريشن |
Hereditary calcitonin polypeptide receptor antagonists
|
CN1780820A
(zh)
|
2003-04-28 |
2006-05-31 |
埃科特莱茵药品有限公司 |
作为阿立新受体拮抗剂的喹喔啉-3-酮衍生物
|
JP3939744B2
(ja)
|
2003-06-11 |
2007-07-04 |
メルク エンド カムパニー インコーポレーテッド |
置換3−アルキルおよび3−アルケニルアゼチジン誘導体
|
HUP0304101A3
(en)
|
2003-12-22 |
2008-10-28 |
Sanofi Aventis |
Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
WO2005118548A1
(fr)
|
2004-03-01 |
2005-12-15 |
Actelion Pharmaceuticals Ltd |
Derives de 1,2,3,4-tétrahydroisoquinoléine substitués
|
WO2006067224A2
(fr)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Nouveaux composes
|
DE102004062544A1
(de)
|
2004-12-24 |
2006-07-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Pyrrolidinone, deren Herstellung und deren Verewendung als Arzneimittel
|
WO2006110626A1
(fr)
|
2005-04-12 |
2006-10-19 |
Merck & Co., Inc. |
Antagonistes du récepteur de l’orexine de type amidopropoxyphényle
|
WO2006113704A2
(fr)
*
|
2005-04-18 |
2006-10-26 |
Neurogen Corporation |
Antagonistes cb1 heteroaryle substitue
|
WO2006117669A1
(fr)
|
2005-05-03 |
2006-11-09 |
Pfizer Inc. |
Composes d'amide resorcinol
|
JP2008542276A
(ja)
|
2005-05-23 |
2008-11-27 |
メルク エンド カムパニー インコーポレーテッド |
プロリンビスアミドオレキシン受容体アンタゴニスト
|
WO2007019234A2
(fr)
|
2005-08-04 |
2007-02-15 |
Merck & Co., Inc. |
Antagonistes des recepteurs d'orexine a base de sulfamide d'aminoethane
|
WO2007025069A2
(fr)
|
2005-08-26 |
2007-03-01 |
Merck & Co., Inc. |
Diazaspirodecane utilise comme antagonistes de recepteurs d'orexine
|
AR055203A1
(es)
*
|
2005-08-31 |
2007-08-08 |
Otsuka Pharma Co Ltd |
Derivados de benzotiofeno con propiedades antipsicoticas
|
EP1954276A2
(fr)
|
2005-11-22 |
2008-08-13 |
Merck & Co., Inc. |
Antagonistes des recepteurs de l'indole orexine
|
AU2007245037A1
(en)
|
2006-03-29 |
2007-11-08 |
Merck Sharp & Dohme Corp. |
Diazepan orexin receptor antagonists
|
US20090105318A1
(en)
|
2006-03-29 |
2009-04-23 |
Coleman Paul J |
Amidoethylthioether Orexin Receptor Antagonists
|
EP2007717A1
(fr)
|
2006-04-11 |
2008-12-31 |
Actelion Pharmaceuticals Ltd. |
Nouveaux composés sulfonamides
|
EP2013209B1
(fr)
|
2006-04-26 |
2011-01-19 |
Actelion Pharmaceuticals Ltd. |
Dérivés de pyrazolo-tétrahydropyridine en tant qu'antagonistes des récepteurs d'orexine
|
US20090192143A1
(en)
|
2006-07-14 |
2009-07-30 |
Cox Christopher D |
Substituted diazepan orexin receptor antagonists
|
EP2049526A2
(fr)
|
2006-07-14 |
2009-04-22 |
Merck & Co., Inc. |
Prolines bis-amides substituées en 2 antagonistes du récepteur de l'oréxine
|
CA2657623A1
(fr)
|
2006-07-14 |
2008-01-17 |
Merck & Co., Inc. |
Diazepans pontes antagonistes du recepteur de l'orexine
|
AU2007285371A1
(en)
|
2006-08-15 |
2008-02-21 |
Actelion Pharmaceuticals Ltd. |
Azetidine compounds as orexin receptor antagonists
|
CA2659352A1
(fr)
|
2006-08-28 |
2008-03-06 |
Actelion Pharmaceuticals Ltd |
Derives de 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene en tant qu'antagonistes de recepteur d'orexine
|
DE602007009284D1
(de)
|
2006-09-29 |
2010-10-28 |
Actelion Pharmaceuticals Ltd |
3-aza-bicycloä3.1.0ühexanderivate
|
ATE496043T1
(de)
*
|
2006-12-01 |
2011-02-15 |
Actelion Pharmaceuticals Ltd |
3-heteroaryl (amino bzw. amido)-1- (biphenyl bzw. phenylthiazolyl) carbonylpiperdinderivate als orexinrezeptor-inhibitoren
|
PE20081229A1
(es)
|
2006-12-01 |
2008-08-28 |
Merck & Co Inc |
Antagonistas de receptor de orexina de diazepam sustituido
|
EP2131654A4
(fr)
*
|
2007-03-02 |
2011-02-02 |
Merck Sharp & Dohme |
Carboxamides de bipyridine, antagonistes du récepteur de l'orexine
|
RU2470021C2
(ru)
|
2007-05-23 |
2012-12-20 |
Мерк Шарп Энд Домэ Корп. |
Пиридилпиперидиновые антагонисты рецептора орексинов
|
EP2184981A4
(fr)
*
|
2007-08-09 |
2012-02-01 |
Merck Sharp & Dohme |
Antagonistes de récepteurs d'orexine au pyridinecarboxamide
|
EP2234999A1
(fr)
*
|
2007-12-21 |
2010-10-06 |
F. Hoffmann-La Roche AG |
Dérivés hétéroaryles en tant qu'antagonistes du récepteur à orexine
|
AR070221A1
(es)
*
|
2008-01-23 |
2010-03-25 |
Astrazeneca Ab |
Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas.
|
WO2009133522A1
(fr)
|
2008-04-30 |
2009-11-05 |
Actelion Pharmaceuticals Ltd |
Composés de pipéridine et de pyrrolidine
|
CA2724648A1
(fr)
*
|
2008-05-22 |
2009-11-26 |
Merck Sharp & Dohme Corp. |
Procede de preparation d'un antagoniste des recepteurs de l'orexine
|
US8623863B2
(en)
|
2008-10-21 |
2014-01-07 |
Merck Sharp & Dohme Corp. |
Disubstituted azepan orexin receptor antagonists
|
US8466281B2
(en)
|
2008-10-21 |
2013-06-18 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted morpholine orexin receptor antagonists
|
JP2012506375A
(ja)
|
2008-10-21 |
2012-03-15 |
メルク・シャープ・エンド・ドーム・コーポレイション |
2,5−二置換ピペリジンオレキシン受容体アンタゴニスト
|
EP2350066B1
(fr)
|
2008-10-21 |
2013-08-28 |
Merck Sharp & Dohme Corp. |
Pipéridines 2,5-disubstituées comme antagonistes du récepteur de l orexine
|
AU2009307918A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
2,4-disubstituted pyrrolidine orexin receptor antagonists
|
EP2350061B1
(fr)
*
|
2008-10-21 |
2013-08-14 |
Merck Sharp & Dohme Corp. |
Antagonistes de récepteur de l'orexine de type pipéridine 2,3-disubstituée
|
CA2741648A1
(fr)
*
|
2008-10-30 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Antagonistes carboxamide phenyl 2,5-disubstitue du recepteur de l'orexine
|
CA2741644C
(fr)
*
|
2008-10-30 |
2013-05-07 |
Merck Sharp & Dohme Corp. |
Antagonistes d'isonicotinamide des recepteurs de l'orexine
|
GB0823467D0
(en)
|
2008-12-23 |
2009-01-28 |
Glaxo Group Ltd |
Novel Compounds
|
JP2013502447A
(ja)
|
2009-08-24 |
2013-01-24 |
グラクソ グループ リミテッド |
睡眠障害の治療のためのオレキシン受容体アンタゴニストとしての5−メチル−ピペリジン誘導体
|
US9546152B2
(en)
*
|
2012-10-23 |
2017-01-17 |
Merck Sharp & Dohme Corp. |
2-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonists
|